Lucas; Sophie
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lucas; Sophie.The latest application filed is for "garp-tgf-beta antibodies".
- Lucas; Sophie - Duisburg BE
- Lucas; Sophie - Tervuren BE
- Lucas; Sophie - Brussels BE
| Patent | Date |
|---|---|
| Anti-GARP protein Grant 11,230,603 - Lucas , et al. January 25, 2 | 2022-01-25 |
| Garp-tgf-beta Antibodies App 20210324061 - van der Woning; Sebastian ; et al. | 2021-10-21 |
| Nucleic acids encoding GARP-TGF-beta 1 antibodies Grant 10,875,914 - van der Woning , et al. December 29, 2 | 2020-12-29 |
| Method of screening for anti-GARP antibodies Grant 10,822,424 - Lucas , et al. November 3, 2 | 2020-11-03 |
| GARP-TGF-.beta. 1 IGG antibodies Grant 10,793,627 - van der Woning , et al. October 6, 2 | 2020-10-06 |
| Anti-garp Protein And Uses Thereof App 20200181276 - Lucas; Sophie ; et al. | 2020-06-11 |
| Antibody against a complex between human GARP and latent TGF-.beta. Grant 10,604,579 - Lucas , et al. | 2020-03-31 |
| Garp-tgf-beta 1 Antibodies App 20200095311 - van der Woning; Sebastian ; et al. | 2020-03-26 |
| Anti-garp Protein And Uses Thereof App 20200087404 - Lucas; Sophie ; et al. | 2020-03-19 |
| Garp-tgf-beta 1 Antibodies App 20190375832 - van der Woning; Sebastian ; et al. | 2019-12-12 |
| GARP-TGF-beta 1 antibodies Grant 10,479,829 - Van der Woning , et al. Nov | 2019-11-19 |
| Anti-garp Protein And Uses Thereof App 20190016811 - Lucas; Sophie ; et al. | 2019-01-17 |
| Garp-tgf-beta Antibodies App 20180327487 - Van der Woning; Sebastian ; et al. | 2018-11-15 |
| Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibody Grant 10,000,572 - Lucas , et al. June 19, 2 | 2018-06-19 |
| Anti-garp Protein And Uses Thereof App 20160272717 - Lucas; Sophie ; et al. | 2016-09-22 |
| Anti-garp Protein And Uses Thereof App 20160251438 - Lucas; Sophie ; et al. | 2016-09-01 |
| Lage-1 tumor associated nucleic acids Grant 7,998,483 - Lethe , et al. August 16, 2 | 2011-08-16 |
| Lage-1 Tumor Associated Nucleic Acids App 20090274716 - Lethe; Bernard ; et al. | 2009-11-05 |
| LAGE-1 tumor associated nucleic acids Grant 7,563,870 - Lethe , et al. July 21, 2 | 2009-07-21 |
| Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof Grant 7,022,819 - Lucas , et al. April 4, 2 | 2006-04-04 |
| LAGE-1 tumor associated nucleic acids App 20040234541 - Lethe, Bernard ; et al. | 2004-11-25 |
| Lage-1 tumor associated nucleic acids Grant 6,794,131 - Lethe , et al. September 21, 2 | 2004-09-21 |
| Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B FAMILIES and uses thereof Grant 6,680,191 - Lucas , et al. January 20, 2 | 2004-01-20 |
| Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof App 20030170256 - Lucas, Sophie ; et al. | 2003-09-11 |
| Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B families and uses thereof App 20020176865 - Lucas, Sophie ; et al. | 2002-11-28 |
| Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof Grant 6,475,783 - Lucas , et al. November 5, 2 | 2002-11-05 |
| Leukemia associated genes Grant 6,130,052 - Van Baren , et al. October 10, 2 | 2000-10-10 |
| Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof Grant 5,997,872 - Lucas , et al. December 7, 1 | 1999-12-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 